![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 10, 7629-7632, March 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Center for Basic Neuroscience, Department of Molecular Genetics, and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9111
Synaptotagmins constitute a family of
membrane-trafficking proteins that are characterized by an N-terminal
TMR,1 a variable linker, and
two C-terminal C2-domains (1). Synaptotagmin 1 (Syt 1) was
identified as p65 in a monoclonal antibody screen for synaptic proteins
(2) and proposed as a potential Ca2+ sensor for regulated
exocytosis when its cloning revealed the presence of two
C2-domains (3). Twelve additional synaptotagmins were
subsequently discovered (Fig. 1 and Table
I; Refs. 4-14). Extensive work showed
that Syts 1 and 2 likely function as Ca2+ sensors in
synaptic vesicle exocytosis (15-19). Much less is known about the
other synaptotagmins, although many of them are abundantly co-expressed
with Syts 1 and 2 in brain and are evolutionarily conserved. The most
abundant of these "other" synaptotagmins, Syts 3 and 7, are
localized on the plasma membrane opposite to synaptic vesicles and
exhibit distinct Ca2+ affinities, suggesting that plasma
membrane and vesicular synaptotagmins may function as complementary
Ca2+ sensors in exocytosis with a hierarchy of
Ca2+ affinities (20-22). In the present short review, I
shall discuss the synaptotagmin family as a whole and evaluate possible
biological reasons for the co-expression of multiple isoforms.
We classify as a synaptotagmin any protein that has an N-terminal
TMR, a central linker, and two C-terminal C2-domains (Fig. 1). Based on their sequences and
properties, the 13 vertebrate synaptotagmins can be grouped into 6 classes (Table I).
![]()
INTRODUCTION
TOP
INTRODUCTION
Structures of Synaptotagmins
Genes and Alternative Splicing...
Synaptotagmin C2-Domains
Functional Properties of...
A Working Model for...
REFERENCES
Properties of synaptotagmins
![]()
Structures of Synaptotagmins
TOP
INTRODUCTION
Structures of Synaptotagmins
Genes and Alternative Splicing...
Synaptotagmin C2-Domains
Functional Properties of...
A Working Model for...
REFERENCES

View larger version (28K):
[in a new window]
Fig. 1.
Domain structures of synaptotagmins 1-13:
relation of protein domains to the intron/exon organization of the
human genes. Each diagram shows a single or several closely
related synaptotagmins as identified on the left.
Arrows indicate positions of introns in the corresponding
human genes as identified in the human genome sequence.2
The numbers next to the arrows describe the position in the
codon at which the coding sequence is interrupted by the intron
(0, at the codon junction; 1 and 2,
after the first and second codon position, respectively). The
N-terminal TMR is marked with a T, and the C2A-
and C2B-domains are labeled.
Fig. 1 displays the domain structures of synaptotagmins and the
positions of the introns in the corresponding human
genes.2 The N-terminal
sequences preceding the TMRs are usually short (4-62 residues) and
exhibit significant sequence similarity only within a given class. Syts
1 and 2 are the only synaptotagmins with an N-glycosylated N
terminus (4, 23), and Syts 3, 5, 6, and 10 are the only synaptotagmins
with disulfide-bonded cysteines at the N terminus (24). The TMRs of
synaptotagmins also lack significant sequence similarity. In all
synapotagmins except for Syt 13, an intron is placed just N-terminal to
the TMR,2 and all synaptotagmins except for Syt 12 contain
cysteine residues at the cytoplasmic boundary of the TMR. At least in
Syts 1 and 7, some of these cysteines are palmitoylated (25-27).
Synaptotagmins form constitutive dimers via their TMRs in a reaction
that may require palmitoylation (23, 27). One possible reason for the constitutive dimerization of synaptotagmins is to protect them from
cleavage by
-secretase since
-secretase promiscuously cleaves monomeric but not dimeric membrane proteins containing a short extracellular stub (28). The size of the linker between the TMR and the
C2-domains varies from 43 residues for Syt 8 to 417 residues for the longest splice variant of Syt 7 (Fig. 1). At least in
Syt 1, the linker is phosphorylated by multiple protein kinases (29,
30).
The C-terminal C2-domains of synaptotagmins, referred to as
the C2A- and C2B-domains, account for the
majority of their sequences and represent their only homologous
sequences (Fig. 1). C2-domains are widespread modules of
130-140 residues that were initially defined as the second constant
sequence (hence "C2") in protein kinase C isoforms (31)
and were first shown in Syt 1 to constitute Ca2+-binding
modules (32-34). Atomic structures revealed that the synaptotagmin C2A- and C2B-domains are similarly composed of
a
-sandwich containing eight
-strands, with flexible loops
emerging from the top and the bottom (35, 36).
C2A-domains generally bind three Ca2+ ions,
whereas C2B-domains bind only two Ca2+ ions
(Fig. 3) (Refs. 36-38; but see below for exceptions). All C2B-domains contain a bottom
-helix between the 7th and
8th
-strands that is absent from C2A-domains (35-38).
The fact that the differences between the C2A- and
C2B-domains are conserved indicates a common ancestry and
suggests that the C2-domains are functionally specialized in all synaptotagmins (1).
In addition to synaptotagmins, proteins such as rabphilin and Doc2s
contain similar C2A- and C2B-domains but are
not classified as synaptotagmins because they lack TMRs (reviewed in
Ref. 1). Furthermore, two other protein families (called Vp115
and ferlins) contain multiple C2-domains and a TMR similar
to synaptotagmins but differ from synaptotagmins in that they have more
than two C2-domains (39-44).
| |
Genes and Alternative Splicing of Synaptotagmins |
|---|
|
|
|---|
Analysis of the human genome revealed that synaptotagmin genes vary from <10 kilobases (Syts 8 and 9) to >60 kilobases (Syt 1), and are not physically linked.2 The exon/intron structures of synaptotagmin genes are nearly identical for synaptotagmins within a class but differ dramatically between classes. Some synaptotagmin genes are relatively simple (e.g. the Syt 4 and 11 genes contain only four exons), whereas others are complex (the Syt 7 gene with 14 exons; Fig. 1). Only a single exon (at the beginning of the C2B-domain) is shared among all synaptotagmins, making this exon a signature of synaptotagmin genes.
Alternative splicing of the linker sequence between the TMR and the C2-domains of synaptotagmins and of the TMR itself have been reported. Alternative splicing of a short sequence in the linker of Syt 1 (3) probably represents a sliding exon/intron junction. Strikingly, the Syt 7 linker region is subject to extensive alternative splicing with dramatic changes in protein structure (21). Five exons are variably included or excluded in the mRNA (Fig. 1), resulting in a 10-fold expansion or contraction of the linker. One of the five alternatively spliced exons features an evolutionarily conserved stop codon; insertion of this exon creates a truncated Syt 7 protein (21). The alternative splicing of Syt 7 is developmentally and regionally regulated, suggesting that it regulates the coupling of the C2-domains to the TMR (21).
PCR experiments suggested that for many synaptotagmins, variants
lacking TMRs are produced by "exon skipping" (45, 46). However, the
gene structures of these synaptotagmins show that exon skipping would
create out-of-frame junctions between the N- and C-terminal exons (Fig.
1). This result together with the fact that no soluble synaptotagmins
were observed make the alternative splicing of synaptotagmin TMRs doubtful.
| |
Synaptotagmin C2-Domains |
|---|
|
|
|---|
The synaptotagmin C2-domains are functionally
polarized in that Ca2+ exclusively binds to the top loops
but not the bottom loops (36-38, 47, 48). Diverse activities
have been reported for synaptotagmin C2-domains. In
assessing potential interactions of C2-domains, structural
implications are unfortunately often ignored in favor of
"functional" interpretations. For example, experiments with peptide
injections into nerve terminals (49) led to the conclusion that the
characteristic C-terminal WHXL sequence of the Syt 1 C2B-domain functions in synaptic vesicle docking. In the
folded C2B-domain, however, the WHXL sequence
forms a stably bonded
-strand (36) that is unlikely to unfold under
physiological conditions. Another example is the AD3 mutant in
Drosophila (18, 19). The AD3 mutation changes a conserved
-strand of the C2B-domain and likely interferes with its
folding. Claims about testing specific binding activities of the
C2B-domain with the AD3 mutant domain (50, 51) are thus
difficult to interpret. Similar reservations apply to other studies of
synaptotagmins that involve sequences with conserved secondary structures.
Ca2+ and Phospholipid
Binding--
C2-domains bind Ca2+ exclusively
via their top loops (33, 47). Fig. 2
shows a model of the Ca2+-binding sites of the Syt 1 C2-domains (36, 38). The Ca2+-binding sites of
C2-domains are unusual because Ca2+ ions are
coordinated by residues that are widely separated in the primary
sequence and because the coordination spheres for the Ca2+
ions are incomplete (16, 47). The intrinsic Ca2+ affinities
of the C2-domains are low (Kd >1
mM and >0.3 mM for the Syt 1 C2A-
and C2B-domains, respectively (16, 36)). Ca2+
binding to C2-domains (except for the unusual
piccolo/aczonin C2-domain (52)) does not cause significant
conformational changes (36-38), suggesting that C2-domains
function as electrostatic switches whereby Ca2+ binding
triggers interactions by altering their surface charge (48).
|
The C2-domains of Syt 1 bind phospholipids as a function of Ca2+ with apparent Ca2+ affinities (1-20 µM Ca2+) that are 100-10,000-fold the intrinsic Ca2+ affinities (16, 36). This dramatic increase probably occurs because the docked phospholipids on top of the C2-domains provide additional coordination sites for the incomplete Ca2+-binding spheres (16, 53). It is likely that phospholipid binding by most synaptotagmins is functionally important but not all synaptotagmins bind Ca2+ and phospholipids. For example, Syts 4 and 11 have an evolutionarily conserved substitution in the Ca2+-binding site of the C2A-domain (Fig. 2; Ref. 11) that prevents binding of a full complement of Ca2+ ions. In Syts 8, 12, and 13, the top loops of the C2A- and the C2B-domains lack almost all of the aspartate and glutamate residues involved in Ca2+ binding.
Ca2+-dependent Self-association-- The recombinant C2B-domains, but not C2A-domains, of most synaptotagmins pull down native Syt 1 and Syt 2 from brain in a Ca2+-dependent manner (54-57). This activity suggests a potential mechanism by which C2B-domains could mediate Ca2+-dependent polymerization of synaptotagmins during exocytosis. Some studies detected Ca2+-dependent multimerization of recombinant C2-domains (56-58), whereas others did not (54, 55). Structural characterization of the Syt 1 C2B-domain revealed that the electrophoretically pure C2B-domain contains stoichiometric amounts of bacterial contaminants (probably polynucleotides and lipids) that are tightly attached to a polybasic sequence (LKKKKT) on the C2B-domain, cause domain aggregation, and are only removed by harsh washes (59). C2B-domain that was cleared of bacterial contaminants exhibited competent Ca2+ binding but no self-association even at millimolar Ca2+ (59), but native Syt 1 formed Ca2+-dependent high molecular weight complexes, indicating that Ca2+-dependent self-association (54, 55) may prove relevant but utilize a more complex mechanism.
Interactions with SNAREs-- Most synaptotagmins bind to syntaxin 1 in a Ca2+-dependent manner (7), suggesting an intersection of the mechanism of fusion (via the SNARE protein syntaxin) with the Ca2+-dependent regulation of fusion (via Syt 1) (reviewed in Ref. 60). However, the precise nature of this interaction is unclear. Binding of Syt 1 to syntaxin, SNAP-25 (another SNARE protein), and assembled SNARE complexes has been reported (7, 51, 61-63). Synaptotagmin-binding sites on syntaxin have been localized on the N-terminal Habc domain (63) and the C-terminal SNARE motif (61).
Binding to Endocytosis Proteins-- All synaptotagmins tested (Syts 1-7) interact with AP-2 with high affinity (7, 64), and binding is enhanced by hydrophobic peptides (65). Transfection of truncated synaptotagmins inhibits clathrin coat assembly and endocytosis in fibroblasts, suggesting that synaptotagmins have a physiological role in endocytosis (26). In Drosophila, mutations in the stoned gene cause a defect in synaptic vesicle endocytosis and also a mislocalization and destabilization of Syt 1 (66, 67). Mammalian stoned proteins may also interact with Syt 1, suggesting that this could be a general mechanism in synaptic vesicle endocytosis (68, 69).
Binding of Inositol Phosphates--
The
C2B-domains of most synaptotagmins bind to inositol
polyphosphates via the short polybasic sequence that contains bacterial contaminants in recombinant C2B-domains (70). Binding does
not require the folded C2B-domain but is obtained with the
isolated polybasic sequence. Inhibition of neurotransmitter release by inositol polyphosphates suggests that inositol phosphate binding to
synaptotagmin physiologically regulates release (71). However, hundreds
of synaptic proteins may bind to inositol phosphates, and the specific
role of synaptotagmin is unknown.
| |
Functional Properties of Individual Synaptotagmins |
|---|
|
|
|---|
Class 1: Syts 1 and 2 as Vesicular Ca2+ Sensors-- Syts 1 and 2 are localized to synaptic vesicles and secretory granules (2-4, 22), are closely related, and are differentially expressed in a largely non-overlapping pattern (4, 72, 73). Syts 1 and 2 probably function as an essential Ca2+ sensor in fast synaptic vesicle exocytosis (15) as shown by a point mutation that was introduced into the endogenous mouse genome (16). This mutation caused an approximately 2-fold decrease in the apparent Ca2+ affinity of Syt 1 and a similar decrease in the Ca2+ sensitivity of synaptic vesicle exocytosis, indicating that Ca2+ binding to Syt 1 is an essential step in triggering exocytosis. However, Syts 1 and 2 are not the only Ca2+ sensor because some Ca2+-dependent exocytosis remains in their absence (15, 17, 18). In addition to exocytosis, Syt 1 may also function in endocytosis as discussed above.
Class 2: Syt 7 as an Active Zone Ca2+ Sensor-- Syt 7, together with Syt 3, is the most abundant synaptotagmin after Syts 1 and 2. Syt 7 is expressed predominantly in brain (7, 21, 72, 73) where it is primarily present on plasma membranes (20, 21). Confusingly, in cultured cells Syt 7 has been reported in lysosomes (76). However, the antibody used in that study did not detect Syt 7 in brain, making the localization of Syt 7 in non-neuronal cells uncertain. The C2-domains of Syt 7 have a 10-20-fold higher Ca2+ affinity than those of Syts 1 and 2 (22) and self-associate as a function of Ca2+ (77). In permeabilized PC12 cells, recombinant C2A- and C2B-domains of Syt 7 severely inhibit exocytosis (21). C2-domains of Syt 1, by contrast, had no effect consistent with the fact that Syt 1 is not essential for Ca2+-triggered exocytosis in PC12 cells as opposed to synapses (78). Inhibition by recombinant Syt 7 C2-domains required intact Ca2+-binding sites, suggesting that plasma membrane Syt 7 in PC12 cells functions as a Ca2+ sensor for exocytosis.
Class 3: Syts 3, 5, 6, and 10 as Plasma Membrane Ca2+ Sensors-- Similar to Syt 7, Syts 3 and 6 are localized to plasma membranes, have a 10-fold higher Ca2+ affinity than Syts 1 and 2, and probably function in Ca2+-triggered PC12 exocytosis (22, 79). Syt 10 was identified as a seizure-inducible mRNA and may have a function related to neuronal excitability (10).
Class 4: Syts 4 and 11-- Syts 4 and 11 are encoded by the simplest genes among synaptotagmins (Fig. 1). Their characteristic feature is a conserved substitution of an aspartate for a serine residue in the C2A-domain (Fig. 2) that changes the Ca2+-binding properties of the C2A-domain (11). Syt 4 is expressed at highest levels early during postnatal development (79) but is strongly induced by seizures in adult brain (80) and by increases in cAMP or Ca2+ in PC12 cells (81). Immunocytochemistry of brain sections, cultured neurons, and transfected cells localized Syt 4 in the Golgi apparatus (79, 82). In contrast, the Drosophila Syt 4 homolog was observed in synaptic vesicles (83).
The function of Syts 4 and 11 is also uncertain. Microinjection of Syt 4 fragments into PC12 cells (84) and overexpression of Drosophila Syt 4 inhibited exocytosis (83). A knockout of Syt 4 in mice uncovered a subtle but interesting phenotype that is consistent with a modulatory role at the synapse (85). Nothing is known about the expression and localization of Syt 11, but the similarity between Syts 4 and 11 suggests that they are redundant.
Class 5: Syt 9-- Syt 9 (also called Syt 5 (7-9)) is synthesized at low abundance in brain and non-neuronal cells (8, 9) and localized to synaptic vesicles (8).
Class 6: Atypical Syts 8, 12, and 13 That Lack Consensus
Ca2+-binding Sites--
Very little is also known about
these synaptotagmins. Syt 12 was initially discovered as a thyroid
hormone-regulated transcript (12), indicating a specialized function in
brain that could be related to thyroid-dependent
developmental changes.
| |
A Working Model for Synaptotagmin Function |
|---|
|
|
|---|
Vertebrates express at least 13 synaptotagmins that are
synthesized exclusively or predominantly in neurons and neuroendocrine cells. By virtue of their C2-domains, most synaptotagmins
are membrane-bound Ca2+-signaling machines. The presence of
distinct synaptotagmins on the membranes of synaptic vesicles and
active zones, the membranes that have to fuse during neurotransmitter
release, suggests a potential explanation for the existence of multiple
synaptotagmins. The model in Fig. 3
proposes that at least Syts 1, 2, 3, 6, and 7 perform complementary
functions in Ca2+-triggered exocytosis whereby
Ca2+ binding to each class of synaptotagmins contributes
differently to triggering exocytosis. As Ca2+ sensors, all
synaptotagmins share the same Ca2+ cooperativity and
Ca2+-dependent phospholipid binding but have
distinct Ca2+ binding properties. Vesicular synaptotagmins
have a lower Ca2+ affinity and are more important in fast
synaptic exocytosis than in endocrine exocytosis, the bulk of which is
much slower (15, 16, 75). Plasma membrane synaptotagmins, in contrast,
have a higher Ca2+ affinity and may be more important for
endocrine exocytosis (21, 22). With these distinct properties, the
combination and relative abundance of various synaptotagmins could
contribute to shaping the characteristic Ca2+ responses of
synapses.
|
Although the model proposed for synaptotagmin function (Fig. 3) is
attractive because it provides an explanation for the unprecedented Ca2+ control of neurotransmitter release, it is as yet only
a working hypothesis. Questions abound. For example, is
Ca2+ binding to a single type of synaptotagmin sufficient
to trigger exocytosis, what is the functional relation between
different C2-domains of synaptotagmins, and how do
synaptotagmins precisely work in exocytosis? If synaptotagmins are
Ca2+-signaling machines, why do some synaptotagmins lack
Ca2+-binding sites? Another set of questions regards the
potential role of synaptotagmins in endocytosis and the possibility
that at least some of them may be expressed outside of neurons and endocrine cells. Addressing these questions will be essential for
further progress.
| |
ACKNOWLEDGEMENTS |
|---|
I thank Drs. J. Rizo, R. Jahn, and E. Kavalali for innumerable discussions.
| |
FOOTNOTES |
|---|
* This minireview will be reprinted in the 2002 Minireview Compendium, which will be available in December, 2002.
To whom correspondence should be addressed: Center for
Basic Neuroscience, Dept. of Molecular Genetics, Howard Hughes
Medical Inst., University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd. NA4.118, Dallas, TX 75390-9111. Tel.: 214-648-1976; Fax: 214-648-1879; E-mail: Thomas.Sudhof@UTSouthwestern.edu.
Published, JBC Papers in Press, December 5, 2001, DOI 10.1074/jbc.R100052200
2 T. C. Südhof, unpublished observation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: TMR, transmembrane region; Syt 1-Syt 13, synaptotagmins 1-13; SNARE, soluble N-ethylmaleimide-sensitive factor attachment protein receptor; AP-2, adaptor protein 2.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Südhof, T. C., and Rizo, J. (1996) Neuron 17, 379-388[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Matthew, W. D.,
Tsavaler, L.,
and Reichardt, L. F.
(1981)
J. Cell Biol.
91,
257-269 |
| 3. | Perin, M. S., Fried, V. A., Mignery, G. A., Jahn, R., and Südhof, T. C. (1990) Nature 345, 260-263[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Geppert, M.,
Archer, B. T., III,
and Südhof, T. C.
(1991)
J. Biol. Chem.
266,
13548-13552 |
| 5. |
Mizuta, M.,
Inagaki, N.,
Nemoto, Y.,
Matsukura, S.,
Takahashi, M.,
and Seino, S.
(1994)
J. Biol. Chem.
269,
11675-11678 |
| 6. |
Hilbush, B. S.,
and Morgan, J. I.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8195-8199 |
| 7. | Li, C., Ullrich, B., Zhang, Z. Z., Anderson, R. G. W., Brose, N., and Südhof, T. C. (1995) Nature 375, 594-599[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Hudson, A. W.,
and Birnbaum, M. J.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5895-5899 |
| 9. | Craxton, M., and Goedert, M. (1995) FEBS Lett. 361, 196-200[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Babity, J. M.,
Armstrong, J. N.,
Plumier, J. C.,
Currie, R. W.,
and Robertson, H. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2638-2641 |
| 11. |
von Poser, C.,
Ichtchenko, K.,
Shao, X.,
Rizo, J.,
and Südhof, T. C.
(1997)
J. Biol. Chem.
272,
14314-14319 |
| 12. |
Thompson, C. C.
(1996)
J. Neurosci.
16,
7832-7840 |
| 13. | von Poser, C., and Südhof, T. C. (2000) Eur. J. Cell Biol. 80, 41-47 |
| 14. | Fukuda, M., and Mikoshiba, K. (2001) Biochem. J. 354, 249-257[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Geppert, M., Goda, Y., Hammer, R. E., Li, C., Rosahl, T. W., Stevens, C. F., and Südhof, T. C. (1994) Cell 79, 717-727[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Fernandez-Chacon, R., Konigstorffer, Gerber, S. H., Garcia, J., Matos, M. F., Stevens, C. F., Brose, N., Rizo, J., Rosenmund, C., and Südhof, T. C. (2001) Nature 410, 41-49[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Nonet, M. L., Grundahl, K., Meyer, B. J., and Rand, J. B. (1993) Cell 73, 1291-1305[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | DiAntonio, A., Parfitt, K. D., and Schwarz, T. L. (1993) Cell 73, 1281-1290[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Littleton, J. T., Stern, M., Schulze, K., Perin, M., and Bellen, H. J. (1993) Cell 74, 1125-1134[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Butz, S.,
Fernandez-Chacon, R.,
Schmitz, F.,
Jahn, R.,
and Südhof, T. C.
(1999)
J. Biol. Chem.
274,
18290-18296 |
| 21. | Sugita, S., Han, W., Butz, S., Liu, X., Fernandez-Chacon, R., Lao, Y., and Südhof, T. C. (2001) Neuron 30, 459-473[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Sugita, S., Shin, O.-K., Han, W., Lao, Y., and Südhof, T. C. (2002) EMBO J., in press |
| 23. |
Perin, M. S.,
Brose, N.,
Jahn, R.,
and Südhof, T. C.
(1991)
J. Biol. Chem.
266,
623-629 |
| 24. |
Fukuda, M.,
Kanno, E.,
and Mikoshiba, K.
(1999)
J. Biol. Chem.
274,
31421-31427 |
| 25. | Chapman, E. R., Blasi, J., An, S., Brose, N., Johnston, P. A., Südhof, T. C., and Jahn, R. (1996) Biochem. Biophys. Res. Commun. 225, 326-332[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Veit, M., Sollner, T. H., and Rothman, J. E. (1996) FEBS Lett. 385, 119-123[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
von Poser, C.,
Zhang, J. Z.,
Mineo, C.,
Ding, W.,
Ying, Y.,
Südhof, T. C.,
and Anderson, R. G. W.
(2000)
J. Biol. Chem.
275,
30916-30924 |
| 28. | Struhl, G., and Adachi, A. (2000) Mol. Cell. 6, 625-636[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Davletov, B.,
Sontag, J. M.,
Hata, Y.,
Petrenko, A. G.,
Fykse, E. M.,
Jahn, R.,
and Südhof, T. C.
(1993)
J. Biol. Chem.
268,
6816-6822 |
| 30. | Hilfiker, S., Pieribone, V. A., Nordstedt, C., Greengard, P., and Czernik, A. J. (1999) J. Neurochem. 73, 921-932[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Coussens, L.,
Parker, P. J.,
Rhee, L.,
Yang-Feng, T. L.,
Chen, E.,
Waterfield, M. D.,
Francke, U.,
and Ullrich, A.
(1986)
Science
233,
859-866 |
| 32. |
Davletov, B.,
and Südhof, T. C.
(1993)
J. Biol. Chem.
268,
26386-26390 |
| 33. |
Rizo, J.,
and Südhof, T. C.
(1998)
J. Biol. Chem.
273,
15879-15882 |
| 34. | Nalefski, E. A., and Falke, J. J. (1996) Protein Sci. 5, 2375-2390[Abstract] |
| 35. | Sutton, A. B., Davletov, B. A., Berghuis, A. M., Südhof, T. C., and Sprang, S. R. (1994) Cell 80, 929-938 |
| 36. | Fernandez, I., Arac, D., Ubach, J., Gerber, S. H., Shin, O., Gao, Y., Anderson, R. G. W., Südhof, T. C., and Rizo, J. (2001) Neuron 32, 1057-1069[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Ubach, J., Garcia, J., Nittler, M. P., Südhof, T. C., and Rizo, J. (1999) Nat. Cell Biol. 1, 106-112[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Ubach, J., Zhang, X., Shao, X., Südhof, T. C., and Rizo, J. (1998) EMBO J. 17, 3921-3930[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Morris, N. J., Ross, S. A., Neveu, J. M., Lane, W. S., and Lienhard, G. E. (1999) Biochim. Biophys. Acta 1431, 525-530[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Achanzar, W. E., and Ward, S. (1997) J. Cell Sci. 110, 1073-1081[Abstract] |
| 41. | Britton, S., Freeman, T., Vafiadaki, E., Keers, S., Harrison, R., Bushby, K., and Bashir, R. (2000) Genomics 68, 313-321[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Bashir, R., Britton, S., Strachan, T., Keers, S., Vafiadaki, E., Lako, M., Richard, I., Marchand, S., Bourg, N., Argov, Z., Sadeh, M., Mahjneh, I., Marconi, G., Passos-Bueno, M. R., Moreira, E. D, Zatz, M., Beckmann, J. S., and Bushby, K. (1998) Nat. Genet. 20, 37-42[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Liu, J., Aoki, M., Illa, I., Wu, C., Fardeau, M., Angelini, C., Serrano, C., Urtizberea, J. A., Hentati, F., Hamida, M. B., Bohlega, S., Culper, E. J., Amato, A. A., Bossie, K., Oeltjen, J., Bejaoui, K., McKenna-Yasek, D., Hosler, B. A., Schurr, E., Arahata, K., de Jong, P. J., and Brown, R. H. (1998) Nat. Genet. 20, 31-36[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Yasunaga, S., Grati, M., Chardenoux, S., Smith, T. N., Friedman, T. B., Lalwani, A. K., Wilcox, E. R., and Petit, C. (2000) Am. J. Hum. Genet. 67, 591-600[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Craxton, M., and Goedert, M. (1999) FEBS Lett. 460, 417-422[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Fukuda, M.,
and Mikoshiba, K.
(1999)
J. Biol. Chem.
274,
31428-31434 |
| 47. | Shao, X., Davletov, B. A., Sutton, R. B., Südhof, T. C., and Rizo, J. (1996) Science 273, 248-251[Abstract] |
| 48. | Shao, X., Li, C., Fernandez, I., Zhang, X., Südhof, T. C., and Rizo, J. (1997) Neuron 18, 133-142[CrossRef][Medline] [Order article via Infotrieve] |
| 49. |
Fukuda, M.,
Moreira, J. E.,
Liu, V.,
Sugimori, M.,
Mikoshiba, K.,
and Llinas, R. R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
14715-14719 |
| 50. | Fukuda, M., Kabayama, H., and Mikoshiba, K. (2000) FEBS Lett. 482, 269-272[CrossRef][Medline] [Order article via Infotrieve] |
| 51. |
Littleton, J. T.,
Bai, J.,
Vyas, B.,
Desai, R.,
Baltus, A. E.,
Garment, M. B.,
Carlson, S. D.,
Ganetzky, B.,
and Chapman, E. R.
(2001)
J. Neurosci.
21,
1421-1433 |
| 52. | Gerber, S. H., Garcia, J., Rizo, J., and Südhof, T. C. (2001) EMBO J. 20, 1605-1619[CrossRef][Medline] [Order article via Infotrieve] |
| 53. | Zhang, X., Rizo, J., and Südhof, T. C. (1998) Biochemistry 37, 12395-12403[CrossRef][Medline] [Order article via Infotrieve] |
| 54. |
Sugita, S.,
Hata, Y.,
and Südhof, T. C.
(1996)
J. Biol. Chem.
271,
1262-1265 |
| 55. |
Chapman, E. R., An, S.,
Edwardson, J. M.,
and Jahn, R.
(1996)
J. Biol. Chem.
271,
5844-5849 |
| 56. | Damer, C. K., and Creutz, C. E. (1996) J. Neurochem. 67, 1661-1668[Medline] [Order article via Infotrieve] |
| 57. |
Osborne, S. L.,
Herreros, J.,
Bastiaens, P. I.,
and Schiavo, G.
(1999)
J. Biol. Chem.
274,
59-66 |
| 58. |
Desai, R. C.,
Vyas, B.,
Earles, C. A.,
Littleton, J. T.,
Kowalchyck, J. A.,
Martin, T. F.,
and Chapman, E. R.
(2000)
J. Cell Biol.
150,
1125-1136 |
| 59. | Ubach, J., Lao, Y., Fernandez, I., Arac, D., Südhof, T. C., and Rizo, J. (2001) Biochemistry 40, 5854-5860[CrossRef][Medline] [Order article via Infotrieve] |
| 60. | Südhof, T. C. (1995) Nature 375, 645-653[CrossRef][Medline] [Order article via Infotrieve] |
| 61. |
Kee, Y.,
and Scheller, R. H.
(1996)
J. Neurosci.
16,
1975-1981 |
| 62. |
Gerona, R. R.,
Larsen, E. C.,
Kowalchyk, J. A.,
and Martin, T. F.
(2000)
J. Biol. Chem.
275,
6328-6336 |
| 63. | Fernandez, I., Ubach, J., Dulubova, I., Zhang, X., Südhof, T. C., and Rizo, J. (1998) Cell 94, 841-849[CrossRef][Medline] [Order article via Infotrieve] |
| 64. | Zhang, J. Z., Davletov, B. A., Südhof, T. C., and Anderson, R. G. W. (1994) Cell 78, 751-760[CrossRef][Medline] [Order article via Infotrieve] |
| 65. |
Haucke, V.,
and De Camilli, P.
(1999)
Science
285,
1268-1271 |
| 66. |
Fergestad, T.,
and Broadie, K.
(2001)
J. Neurosci.
21,
1218-1227 |
| 67. |
Phillips, A. M.,
Smith, M.,
Ramaswami, M.,
and Kelly, L. E.
(2000)
J. Neurosci.
20,
8254-8261 |
| 68. |
Martina, J. A.,
Bonangelino, C. J.,
Aguilar, R. C.,
and Bonifacino, J. S.
(2001)
J. Cell Biol.
153,
1111-1120 |
| 69. | Walther, K., Krauss, M., Diril, M. K., Lemke, S., Ricotta, D., Honing, S., Kaiser, S., and Haucke, V. (2001) EMBO Rep. 2, 634-640[CrossRef][Medline] [Order article via Infotrieve] |
| 70. |
Ibata, K.,
Fukuda, M.,
and Mikoshiba, K.
(1998)
J. Biol. Chem.
273,
12267-12273 |
| 71. |
Llinas, R,
Sugimori, M.,
Lang, E. J.,
Morita, M.,
Fukuda, M.,
Niinobe, M.,
and Mikoshiba, K.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
12990-12993 |
| 72. | Ullrich, B., Li, C., Zhang, J. Z., McMahon, H., Anderson, R. G., Geppert, M., and Südhof, T. C. (1994) Neuron 13, 1281-1291[CrossRef][Medline] [Order article via Infotrieve] |
| 73. | Marqueze, B., Boudier, J. A., Mizuta, M., Inagaki, N., Seino, S., and Seagar, M. (1995) J. Neurosci. 15, 4906-4917[Abstract] |
| 74. | Marqueze, B., Berton, F., and Seagar, M. (2000) Biochimie (Paris) 82, 409-420[Medline] [Order article via Infotrieve] |
| 75. |
Voets, T.,
Moser, T.,
Lund, P. E.,
Chow, R. H.,
Geppert, M.,
Südhof, T. C.,
and Neher, E.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
11680-11685 |
| 76. |
Martinez, I.,
Chakrabarti, S.,
Hellevik, T.,
Morehead, J.,
Fowler, K.,
and Andrews, N. W.
(2000)
J. Cell Biol.
148,
1141-1149 |
| 77. |
Fukuda, M.,
and Mikoshiba, K.
(2001)
J. Biol. Chem.
276,
27670-27676 |
| 78. | Shoji-Kasai, Y., Yoshida, A., Sato, K., Hoshino, T., Ogura, A., Kondo, S., Fujimoto, Y., Kuwahara, R., Kato, R., and Takahashi, M. (1992) Science 256, 1821-1823[CrossRef][Medline] [Order article via Infotrieve] |
| 79. | Berton, F., Cornet, V., Iborra, C., Garrido, J., Dargent, B., Fukuda, M., Seagar, M., and Marqueze, B. (2000) Eur. J. Neurosci. 12, 1294-1302[CrossRef][Medline] [Order article via Infotrieve] |
| 80. |
Vician, L.,
Lim, I. K.,
Ferguson, G.,
Tocco, G.,
Baudry, M.,
and Herschman, H. R.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
2164-2168 |
| 81. | Ferguson, G. D., Thomas, D. M., Elferink, L. A., and Herschman, H. R. (1999) J. Neurochem. 72, 1821-1831[CrossRef][Medline] [Order article via Infotrieve] |
| 82. | Fukuda, M., Ibata, K., and Mikoshiba, K. (2001) J. Neurochem. 77, 730-740[CrossRef][Medline] [Order article via Infotrieve] |
| 83. | Littleton, J. T., Serano, T. L., Rubin, G. M., Ganetzky, B., and Chapman, E. R. (1999) Nature 400, 757-760[CrossRef][Medline] [Order article via Infotrieve] |
| 84. |
Thomas, D. M.,
Ferguson, G. D.,
Herschman, H. R.,
and Elferink, L. A.
(1999)
Mol. Biol. Cell
10,
2285-2295 |
| 85. |
Ferguson, G. D.,
Anagnostaras, S. G.,
Silva, A. J.,
and Herschman, H. R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
5598-5603 |
This article has been cited by other articles:
![]() |
N. Gustavsson, Y. Lao, A. Maximov, J.-C. Chuang, E. Kostromina, J. J. Repa, C. Li, G. K. Radda, T. C. Sudhof, and W. Han Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice PNAS, March 11, 2008; 105(10): 3992 - 3997. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maximov, Y. Lao, H. Li, X. Chen, J. Rizo, J. B. Sorensen, and T. C. Sudhof Genetic analysis of synaptotagmin-7 function in synaptic vesicle exocytosis PNAS, March 11, 2008; 105(10): 3986 - 3991. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Osborne, P. J. Wen, C. Boucheron, H. N. Nguyen, M. Hayakawa, H. Kaizawa, P. J. Parker, N. Vitale, and F. A. Meunier PIKfyve Negatively Regulates Exocytosis in Neurosecretory Cells J. Biol. Chem., February 1, 2008; 283(5): 2804 - 2813. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Gauthier, D. L. Duhamel, M. Iezzi, S. Theander, F. Saltel, M. Fukuda, B. Wehrle-Haller, and C. B. Wollheim Synaptotagmin VII splice variants {alpha}, , and {delta} are expressed in pancreatic -cells and regulate insulin exocytosis FASEB J, January 1, 2008; 22(1): 194 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Kavalali Multiple vesicle recycling pathways in central synapses and their impact on neurotransmission J. Physiol., December 15, 2007; 585(3): 669 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Lynch, R.R.L. Gerona, E. C. Larsen, R. F. Marcia, J. C. Mitchell, and T.F.J. Martin Synaptotagmin C2A Loop 2 Mediates Ca2+-dependent SNARE Interactions Essential for Ca2+-triggered Vesicle Exocytosis Mol. Biol. Cell, December 1, 2007; 18(12): 4957 - 4968. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. ZHAO and F. PATRICK ROSS Mechanisms of Osteoclastic Secretion Ann. N.Y. Acad. Sci., November 1, 2007; 1116(1): 238 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Grybko, J. P. Bartnik, G. A. Wurth, A. T. Pores-Fernando, and A. Zweifach Calcineurin Activation Is Only One Calcium-dependent Step in Cytotoxic T Lymphocyte Granule Exocytosis J. Biol. Chem., June 22, 2007; 282(25): 18009 - 18017. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Musch, D. L. Arvans, M. M. Walsh-Reitz, K. Uchiyama, M. Fukuda, and E. B. Chang Synaptotagmin I binds intestinal epithelial NHE3 and mediates cAMP- and Ca2+-induced endocytosis by recruitment of AP2 and clathrin Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1549 - G1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gardzinski, D. W. K. Lee, G.-H. Fei, K. Hui, G. J. Huang, H.-S. Sun, and Z.-P. Feng The role of synaptotagmin I C2A calcium-binding domain in synaptic vesicle clustering during synapse formation J. Physiol., May 15, 2007; 581(1): 75 - 90. [Abstract] |